These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7845532)

  • 21. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.
    Faucheux BA; Nillesse N; Damier P; Spik G; Mouatt-Prigent A; Pierce A; Leveugle B; Kubis N; Hauw JJ; Agid Y
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9603-7. PubMed ID: 7568181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron transport in Parkinson's disease.
    Hirsch EC
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study.
    Benisty S; Boissiere F; Faucheux B; Agid Y; Hirsch EC
    Neuroscience; 1998 Oct; 86(3):813-26. PubMed ID: 9692719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases.
    Leveugle B; Faucheux BA; Bouras C; Nillesse N; Spik G; Hirsch EC; Agid Y; Hof PR
    Acta Neuropathol; 1996; 91(6):566-72. PubMed ID: 8781654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease.
    Pearce RK; Owen A; Daniel S; Jenner P; Marsden CD
    J Neural Transm (Vienna); 1997; 104(6-7):661-77. PubMed ID: 9444566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
    Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
    Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
    Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
    Quik M; Spokes EG; Mackay AV; Bannister R
    J Neurol Sci; 1979 Nov; 43(3):429-37. PubMed ID: 521836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of melanized neurons expressing neurotensin receptor messenger RNA in the substantia nigra and the nucleus paranigralis of control and Parkinson's disease brain.
    Yamada M; Yamada M; Richelson E
    Neuroscience; 1995 Jan; 64(2):405-17. PubMed ID: 7700529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease.
    Faucheux BA; Martin ME; Beaumont C; Hunot S; Hauw JJ; Agid Y; Hirsch EC
    J Neurochem; 2002 Oct; 83(2):320-30. PubMed ID: 12423242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoradiography of transferrin receptors in the human brain.
    Griffiths PD; Crossman AR
    Neurosci Lett; 1996 Jun; 211(1):53-6. PubMed ID: 8809846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamate receptors in the substantia nigra of Parkinson's disease brains.
    Difazio MC; Hollingsworth Z; Young AB; Penney JB
    Neurology; 1992 Feb; 42(2):402-6. PubMed ID: 1346548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease.
    Moroo I; Yamada T; Makino H; Tooyama I; McGeer PL; McGeer EG; Hirayama K
    Acta Neuropathol; 1994; 87(4):343-8. PubMed ID: 8017169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.
    Rhodes SL; Buchanan DD; Ahmed I; Taylor KD; Loriot MA; Sinsheimer JS; Bronstein JM; Elbaz A; Mellick GD; Rotter JI; Ritz B
    Neurobiol Dis; 2014 Feb; 62():172-8. PubMed ID: 24121126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycine receptors in the human substantia nigra as defined by [3H]strychnine binding.
    de Montis G; Beaumont K; Javoy-Agid F; Agid Y; Constandinidis J; Lowenthal A; Lloyd KG
    J Neurochem; 1982 Mar; 38(3):718-24. PubMed ID: 6276509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
    Anichtchik OV; Peitsaro N; Rinne JO; Kalimo H; Panula P
    Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of [125I]Bolton Hunter CCK8 and [3H]MK-329 (devazepide) binding to CCK receptors in the substantia nigra/VTA complex and its forebrain projection areas following MPTP-induced hemi-parkinsonism in the monkey.
    Graham WC; Hill DR; Woodruff GN; Sambrook MA; Crossman AR
    Neurosci Lett; 1991 Sep; 131(1):129-34. PubMed ID: 1791971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.
    Piggott MA; Perry EK; Marshall EF; McKeith IG; Johnson M; Melrose HL; Court JA; Lloyd S; Fairbairn A; Brown A; Thompson P; Perry RH
    Biol Psychiatry; 1998 Oct; 44(8):765-74. PubMed ID: 9798081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra.
    Reyes S; Cottam V; Kirik D; Double KL; Halliday GM
    Mov Disord; 2013 Sep; 28(10):1351-9. PubMed ID: 23674405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.